TT International Asset Management »

Denali Therapeutics shares owned by TT International Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by TT International Asset Management from 13F filings

Historical chart of TT International Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by TT International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by TT International Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $944k 65k 14.52
2025-06-30 $909k 65k 13.99

More positions owned by TT International Asset Management

Alibaba Group Hldg Sponsor Ads (BABA)
Pampa Energia S A Spons Adr Lvl I (PAM)
Onto Innovation (ONTO)
Futu Hldgs Spon Ads Cl A (FUTU)
Banco Macro Sa Spon Adr B (BMA)
Banco De Chile Sponsored Ads (BCH)
Ke Hldgs Sponsored Ads (BEKE)
Banco Santander Chile Sp Adr Rep Com (BSAC)
Transportadora De Gas Sur Sponsored Ads B (TGS)
Makemytrip Limited Mauritius SHS
Daqo New Energy Corp Spnsrd Ads New (CYBR)
Ase Technology Hldg Sponsored Ads (ASX)
Nice Sponsored Adr (NICE)
Inter & Co Class A Com (INTR)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for TT International Asset Management

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics